Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. To Assign 15 FDA Inspectors To China In October

This article was originally published in PharmAsia News

Executive Summary

The U.S. government plans to assign as many as 15 inspectors to three major cities in China, beginning in October, to conduct U.S. FDA inspections of drug and other regulated products. In an interview, Michael Leavitt, secretary of Health and Human Services, said China still has not solved all the problems it had with safety of items made for export to the United States, but "they moved aggressively to begin making progress." The first inspectors are to be placed in Beijing, Shanghai and Guangzhou, Leavitt said, but added he does not expect many future problems with Chinese-made drugs and other products. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069382

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel